Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MG8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,385
Award facts
- Contract value 100% obligated
- $24,384.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,384.65 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). The contract, awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, carries a firm fixed-price structure and involves no set-aside designation, indicating competitive procurement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities. The company's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government procurement requirements for essential pharmaceutical commodities across multiple therapeutic domains. This delivery order for an antiemetic medication reflects the company's role in maintaining the pharmaceutical supply chain for military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9MG8?
SPE2DR26F9MG8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9MG8 worth?
The government has obligated $24,385 on SPE2DR26F9MG8.
Is contract SPE2DR26F9MG8 an order under another contract?
Yes. SPE2DR26F9MG8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MG8 competed?
The extent of competition for SPE2DR26F9MG8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award